PD for Fri 04 Oct 2024 - Sigma's undertaking boosts market confidence, oral medication for T2D in children approved, mpox vaccinations reminder, Haleon fellowship, and more
Sentiment strengthens around merger as Sigma shares surge, T2D in children medication to reduce injections, Haleon fellowship to research supplements for osteoarthritis
Pharmacy Daily - a division of Business Publishing Group PO Box 1010 Epping NSW Australia 1710 Level 2, Suite 1 64 Talavera Rd Macquarie Park NSW 2113 Tel: 1300 799 220 ( 61 2 8007 6760)
To ensure you continue to receive email from Pharmacy Daily reliably please add [email protected] to your 'Safe Senders' list and set images to always display. To forward this email to a friend click here To receive your own copy of Pharmacy Daily sign up here. To modify subscription details click here To unsubscribe click here. You are currently receiving the 'Attachment' version of Pharmacy Daily publications. To switch to a clickable link click here. The Therapeutic Goods (Therapeutic Goods Advertising) Instrument 2021 requires strict compliance. View the code at https://www.legislation.gov.au/Series/F2021L01661.
